We are live on ! Find out more
PDM

Penn Davis McFarland Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+32.35%
3 Year Est. Return
+86.8%
5 Year Est. Return
+114.42%
10 Year Est. Return
+392.43%
AUM
$343M
AUM Growth
-$21.2M
Cap. Flow
-$46M
Cap. Flow %
-13.4%
Top 10 Hldgs %
61.01%
Holding
45
New
2
Increased
1
Reduced
22
Closed
5

Top Buys

1
CELG
Celgene Corp
CELG
+$8.34M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.65M
3
GILD icon
Gilead Sciences
GILD
+$1.07M

Top Sells

1
TEVA icon
Teva Pharmaceuticals
TEVA
+$13.6M
2
EPD icon
Enterprise Products Partners
EPD
+$3.38M
3
AAPL icon
Apple
AAPL
+$3.33M
4
QCOM icon
Qualcomm
QCOM
+$2.63M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.52M

Sector Composition

1 Technology 29.23%
2 Energy 23.68%
3 Communication Services 15.24%
4 Healthcare 8.69%
5 Materials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPD icon
1
Enterprise Products Partners
EPD
$82.6B
$30.7M 8.95%
1,111,741
-121,141
-10% -$3.38M
AAPL icon
2
Apple
AAPL
$4.9T
$29.4M 8.58%
819,672
-101,244
-11% -$3.33M
QCOM icon
3
Qualcomm
QCOM
$181B
$28.9M 8.44%
504,857
-45,307
-8% -$2.63M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.22T
$25M 7.28%
601,780
-61,400
-9% -$2.52M
KMI icon
5
Kinder Morgan
KMI
$71.9B
$22.1M 6.45%
1,018,250
-108,618
-10% -$2.37M
MON
6
DELISTED
Monsanto Co
MON
$16.9M 4.92%
148,991
-18,183
-11% -$2.01M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.23T
$15.8M 4.62%
373,660
-51,320
-12% -$2.16M
SLB icon
8
SLB Ltd
SLB
$70.3B
$13.8M 4.04%
177,331
-14,548
-8% -$1.19M
GILD icon
9
Gilead Sciences
GILD
$167B
$13.3M 3.88%
195,819
+15,193
+8% +$1.07M
DELL icon
10
Dell
DELL
$256B
$13.3M 3.87%
738,798
-75,381
-9% -$1.32M
CHKP icon
11
Check Point Software Technologies
CHKP
$14.3B
$12.1M 3.54%
118,250
-21,725
-16% -$2.13M
MAT icon
12
Mattel
MAT
$4.16B
$11.5M 3.34%
447,521
-17,934
-4% -$480K
INOV
13
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$10.9M 3.17%
862,462
-90,496
-9% -$1.05M
LVS icon
14
Las Vegas Sands
LVS
$30.1B
$10.8M 3.16%
189,761
-18,517
-9% -$1.01M
NBL
15
DELISTED
Noble Energy, Inc.
NBL
$10.8M 3.15%
314,846
-28,821
-8% -$1.07M
TFCFA
16
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$10.7M 3.13%
331,103
-32,739
-9% -$1M
ABB
17
DELISTED
ABB Ltd
ABB
$10.1M 2.94%
431,375
-45,436
-10% -$1.04M
XYL icon
18
Xylem
XYL
$29.2B
$8.82M 2.57%
175,583
-19,292
-10% -$940K
CELG
19
DELISTED
Celgene Corp
CELG
$8.68M 2.53%
+69,716
New +$8.34M
BMY icon
20
Bristol-Myers Squibb
BMY
$124B
$7.59M 2.21%
+139,558
New +$7.65M
ACN icon
21
Accenture
ACN
$87.9B
$6.37M 1.86%
53,103
-9,314
-15% -$1.11M
MOS icon
22
The Mosaic Company
MOS
$7.03B
$5.87M 1.71%
201,284
-25,230
-11% -$779K
HON icon
23
Honeywell
HON
$71.3B
$1.69M 0.49%
14,968
– –
DMLP icon
24
Dorchester Minerals
DMLP
$1.31B
$1.36M 0.4%
78,830
-19,400
-20% -$335K
SYT
25
DELISTED
Syngenta Ag
SYT
$1.33M 0.39%
15,000
– –
1
2

Similar funds

EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
JLBC
J.L. Bainbridge & Co Sarasota, Florida $1.12B AUM 25.58% 1-Year Est. Return
WA
Wealth Architects Mountain View, California $1.12B AUM 24.94% 1-Year Est. Return
FBFS
First Business Financial Services Madison, Wisconsin $1.12B AUM 22.16% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.12B AUM 32.75% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return

Penn Davis McFarland's Q1 2017 Portfolio in Review

As of Q1 2017, Penn Davis McFarland held 45 positions worth $343M, down 5.8% from $364M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Penn Davis McFarland withdrew a net $46M in Q1 2017, closing 5 positions and reducing 22 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $13.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Penn Davis McFarland opened a new position in Celgene Corp worth $8.68M.

  • Penn Davis McFarland's largest Q1 2017 buy was Celgene Corp: 69,716 shares worth $8.68M.
  • Penn Davis McFarland added most to Gilead Sciences in Q1 2017, an estimated $1.07M increase.
  • Penn Davis McFarland's biggest Q1 2017 reduction was Enterprise Products Partners, cutting an estimated $3.38M.
  • Penn Davis McFarland fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $13.6M.
  • Penn Davis McFarland's ten largest holdings make up 61% of its $343M portfolio in Q1 2017.
  • Penn Davis McFarland opened 2 new positions and closed 5 in Q1 2017.
  • Penn Davis McFarland's portfolio value fell 5.8% quarter-over-quarter to $343M.

Based on Penn Davis McFarland's 13F filing for Q1 2017, filed 20 Apr 2017.